These final results, together with a previous report demonstrating that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,2 guidance the idea of targeting ACKR3 as a novel approach to modulate the opioid program, which could open new therapeutic avenues for opioid-relevant Issues. By ticking this box and https://actorp639ogw3.yourkwikimage.com/user